Table 1

Similar levels of mixed chimerism in GalT−/− and GalT−/−CR2−/− mice after nonmyeloablative conditioning and H-2-mismatched BMT

Group (donor and recipient)*No.Percentage of donor cells
CD4
B cells
Monocytes
4 wk after preparation8 wk after preparation16 wk after preparation4 wk after preparation8 wk after preparation16 wk after preparation4 wk after preparation8 wk after preparation16 wk after preparation
A (BALB/c and GalTKO) 33.30 ± 27.70 24.70 ± 20.30 25.80 ± 17.60 41.30 ± 28.40 44.20 ± 18.60 42.90 ± 14.30 58.3 ± 17.7 48.6 ± 18.6 44.5 ± 12.8 
B (BALB/c and GalTCR2DKO) 12.80 ± 5.2 42.40 ± 19.3 40.90 ± 18.4 56.40 ± 22.5 59.00 ± 20.7 62.40 ± 17.2§ 53.8 ± 14.5 39.6 ± 15.1 40.5 ± 12.4 
Group (donor and recipient)*No.Percentage of donor cells
CD4
B cells
Monocytes
4 wk after preparation8 wk after preparation16 wk after preparation4 wk after preparation8 wk after preparation16 wk after preparation4 wk after preparation8 wk after preparation16 wk after preparation
A (BALB/c and GalTKO) 33.30 ± 27.70 24.70 ± 20.30 25.80 ± 17.60 41.30 ± 28.40 44.20 ± 18.60 42.90 ± 14.30 58.3 ± 17.7 48.6 ± 18.6 44.5 ± 12.8 
B (BALB/c and GalTCR2DKO) 12.80 ± 5.2 42.40 ± 19.3 40.90 ± 18.4 56.40 ± 22.5 59.00 ± 20.7 62.40 ± 17.2§ 53.8 ± 14.5 39.6 ± 15.1 40.5 ± 12.4 
*

Recipient GalT−/− or GalT−/−Cr2−/− mice were treated with anti-CD4 and anti-CD8 mAbs on day –5, TI and TBI on day 0, and BALB/c BMT on day 0 with 2 × 107 cells.

Chimerism was detected by flow cytometric analysis after staining with FITC-conjugated anti-CD4, anti-CD19, and anti-Mac 1 mAbs, biotinylated anti-H-2Dd mAb, and PE-streptavidin. To analyze CD4 and B-cell chimerism, a lymphocyte forward scatter/side scatter (FSC/SSC) gate was set. To analyze monocyte chimerism, a monocyte FSC/SSC gate was set. The mean ± SD percentage of donor cells in each lineage is shown.

NS compared with GalT−/− chimeras at the same time point.

§

P < .05 compared with GalT−/− chimeras at the same time point.

Close Modal

or Create an Account

Close Modal
Close Modal